User:Michael Hwang: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
| Line 19: | Line 19: | ||
==Research interests== | ==Research interests== | ||
<!-- Feel free to add brief descriptions to your research interests as well --> | <!-- Feel free to add brief descriptions to your research interests as well --> | ||
# Novel regulators of epithelial-mesenchymal transition (EMT) in the context of cancer metastasis | # Novel regulators of epithelial-mesenchymal transition (EMT) in the context of cancer metastasis and cancer stem cells | ||
# Modeling drug resistance, specifically EGFR inhibitors in cancer | # Modeling drug resistance and sensitivity, specifically EGFR inhibitors in cancer | ||
==Publications== | ==Publications== | ||
Revision as of 19:17, 14 September 2011
I am a new member of OpenWetWare!
Contact Info
- Michael Hwang
- Massachusetts Institute of Technology
- Major: Course 20
- Minor: Course 15
- Residence: Baker House, MIT
- Email me through OpenWetWare
Research Summary: I worked in the lab of Prof. Richard Hynes my freshman year, and in the lab of Prof. Robert Weinberg my sophomore year. This past summer, I worked at Genentech, and for two summers in high school I worked at the Fred Hutchinson Cancer Research Center.
Education
- 2013, BS, Massachusetts Institute of Technology
Research interests
- Novel regulators of epithelial-mesenchymal transition (EMT) in the context of cancer metastasis and cancer stem cells
- Modeling drug resistance and sensitivity, specifically EGFR inhibitors in cancer
Publications
- Putzke AP., Ventura AP., Bailey AM., Akture C., Opoku-Ansah J., Celiktas M., Hwang MS., Darling DS., Coleman IM., Nelson PS., Nguyen HM., Corey E., Tewari M., Morrissey C., Vesella RL., Knudsen BS., Metastatic Progression of Prostate Cancer And E-Cadherin: Regulation by Zeb1 and Src Family Kinases. American Journal of Pathology. 2011 Jul; 179(1):400-10. Epub 2011 May 4. PMID:21703419
